ロード中...
Treating C3 glomerulopathy with eculizumab
BACKGROUND: C3 glomerulopathy (C3G) is a rare, but severe glomerular disease with grim prognosis. The complex pathogenesis is just unfolding, and involves acquired as well as inherited dysregulation of the alternative pathway of the complement cascade. Currently, there is no established therapy. Tre...
保存先:
| 出版年: | BMC Nephrol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5767001/ https://ncbi.nlm.nih.gov/pubmed/29329521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0802-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|